The Orphan Therapeutics Accelerator is a non-profit biotech company focused on obtaining and reinitiating development of promising “shelved” clinical stage medicines for ultra-rare conditions and providing a scalable and sustainable commercialization path to get these treatments to patients.

The company leverages its non-profit status, risk-shared agreements, and tax-related incentives to obtain rights to shelved programs and complete development at lower cost in collaboration with a network of affiliated Contract Development and Manufacturing Organizations (CDMOs), Contract Research Organizations (CROs), and other partners.